{"id":"W4213298430","doi":"10.1093/neuonc/nox036.312","title":"P09.57 Clinical trials of VAL-083 in patients with chemoresistant glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Clinical trial; Oncology; Internal medicine; Glioma; Phases of clinical research; Chemotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001262421,0.0009859533,0.001547051,0.000467116,0.0004100288,0.0008518054,0.0008181862,0.0010853,0.004332806],"category_scores_gemma":[0.0007109627,0.0004685853,0.0009739459,0.0005121031,0.0008246464,0.0005902824,0.0005123197,0.002658498,0.0009315938],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008592764,"about_ca_system_score_gemma":0.001589332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001688641,"about_ca_topic_score_gemma":0.005072903,"domain_scores_codex":[0.9996278,0.000191283,0.0000311193,0.00004698387,0.00003153554,0.00007121874],"domain_scores_gemma":[0.9996166,0.0000473452,0.00005175221,0.00002663401,0.00003492318,0.0002227925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6919802,0.03904408,0.00608696,0.001571136,0.001571592,0.0004412592,0.0003646037,0.001780387,0.03695172,0.001149603,0.01141634,0.2076421],"study_design_scores_gemma":[0.4415497,0.5319265,0.01215157,0.000139719,0.0004581187,0.0002556805,0.0001074854,0.0009265387,0.002861124,0.0005993073,0.008983259,0.00004102309],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9771211,0.00681302,0.000542085,0.00157037,0.0004689925,0.00424641,0.001687608,0.0002197095,0.007330829],"genre_scores_gemma":[0.97703,0.005591856,0.001636124,0.003350673,0.0002103163,0.004583262,0.002911696,0.00004087941,0.004645138],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004332806,"threshold_uncertainty_score":0.01449472,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07139444316969258,"score_gpt":0.4071667440077629,"score_spread":0.3357723008380704,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}